Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02982538 · ClinicalTrials.gov registry record · NA
Implementation of Prolonged Exposure in the Military
A NA study of PTSD, sponsored by University of Pennsylvania.
- Completed
- Registry status
- NA
- Development phase
- 128
- Enrollment target
- 3
- Study locations
NCT02982538: Completed NA study of PTSD, sponsored by University of Pennsylvania.
NCT02982538 is a NA study of PTSD that has completed, run by University of Pennsylvania. The registered enrollment target is 128 participants, below the 301-participant average among 154 other PTSD trials with a reported enrollment target (57% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02982538, a NA study of PTSD, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- NA
- Development phase
- 128 participants
- Enrollment target
- 3
- Study locations
Study Summary
This randomized study examines how prolonged exposure (PE) therapy, an evidence-based treatment for posttraumatic stress disorder (PTSD), can be successfully disseminated and implemented in the Army. The study compares two PE training models: Standard PE training, comprised of a 4-day workshop only, and Extended PE training, comprised of a 4-day workshop plus expert case consultation. In addition, patients with posttraumatic stress symptoms receiving psychotherapy from participating providers will be invited to participate. After completing PE training, use of PE components with patients reporting PTS symptoms and clinical outcomes of these participating patients will be monitored for up to 18 months.
Primary Outcome
Provider use of PE components will be assessed using a brief checklist of treatment procedures completed by providers directly following therapy sessions with participating patients.
Conditions Studied
Interventions
- BEHAVIORAL Extended Training in Prolonged Exposure Therapy for PTSD
- BEHAVIORAL Standard Training in Prolonged Exposure Therapy for PTSD
Study Locations (3)
Colorado
- Evans Army Community Hospital (EACH), Ft. Carson - Colorado Springs
Kentucky
- Blanchfield Army Community Hospital (BACH), Ft. Campbell - Fort Campbell North
Texas
- William Beaumont Army Medical Center (WBAMC), Ft. Bliss - El Paso
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 128 participants |
| Start Date | 2012-10 |
| Est. Completion | 2021-09 |
| Phase | NA |
What the finished NCT02982538 record still lists
NCT02982538 is an interventional study that assigns participants to a tested intervention. The registered 128 participants enrollment target is mid-sized for trials with a published cap, below the 301-participant average among 154 other PTSD trials with a reported enrollment target (57% lower).
The record links to 1 condition, with PTSD appearing as the primary indexed condition, and to 2 interventions - of which Extended Training in Prolonged Exposure Therapy for PTSD is the first listed.
NCT02982538 reports a single indexed study location in Colorado, Kentucky, Texas.
Frequently Asked Questions
What is clinical trial NCT02982538 about?
NCT02982538 is a clinical study titled "Implementation of Prolonged Exposure in the Military". This randomized study examines how prolonged exposure (PE) therapy, an evidence-based treatment for posttraumatic stress disorder (PTSD), can be successfully disseminated and implemented in the Army. The study compares two PE training models: Standard PE training, comprised of a 4-day workshop only,...
What is the current status of trial NCT02982538?
This trial is currently completed. It is a NA study. The enrollment target is 128 participants. The study started on 2012-10. Estimated completion is 2021-09.
What conditions does trial NCT02982538 study?
This clinical trial studies the following conditions: PTSD.
What interventions are being tested in trial NCT02982538?
The interventions under investigation include: Extended Training in Prolonged Exposure Therapy for PTSD (BEHAVIORAL), Standard Training in Prolonged Exposure Therapy for PTSD (BEHAVIORAL).
Who is sponsoring clinical trial NCT02982538?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02982538 being conducted?
This trial has 3 study locations across Colorado, Kentucky, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for PTSD
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02982538's enrollment target sits among peer trials
128 51st of 154 higher than 104 of 154 other PTSD trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other PTSD trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Testing an Integrated PTSD and Weight Management Intervention: A Hybrid Type 1 Trial
RECRUITING · NA
-
Treatments for Insomnia in Veterans With PTSD
RECRUITING · NA
-
REstoring Mental Health Through COmmUnity-based Psychological Services in New York City
RECRUITING · NA
-
Recovery Through Inhibitory Learning, Self-Efficacy Building, Problem Solving, and Community Building
RECRUITING · NA
-
Project Safe Guard-Trauma
RECRUITING · NA
-
Neuromodulation of the Fear Extinction Circuit Using Temporally and Anatomically Specific TMS in Humans
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02870738 · 128 participants · Phase 2
Bladder Directed vs. Pelvic Floor Therapy in IC/BPS
- NCT03294460 · 128 participants · Phase 1
Nicotinic Receptor Genetic Variation and Alcohol Reward
- NCT04149977 · 128 participants · NA
Blood Flow Restriction Therapy in Lower Limb Extensor Injuries
- NCT04373057 · 128 participants · Phase 1
Prebiotic Galacto-oligosaccharide and Acute GVHD
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia